Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study content with an error screen. This indicates that access to the study record is blocked.SummaryDifference18%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays an updated revision tag (v3.6.6) replacing the previous version (v3.6.5). This indicates a minor revision to the page metadata.SummaryDifference0.1%

- Check33 days agoChange DetectedA new NIH grant/contract line from 2015 is added to the funding section, and a 2024 publication by the study investigators is listed under Publications. These additions provide additional funding context and demonstrate further scholarly output related to the trial.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study page underwent a minor revision, updating the record from revision v3.6.4 to v3.6.5. This change reflects an updated page version rather than any new study data.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page version updated from v3.6.3 to v3.6.4. This reflects a backend or UI update to the study page rather than changes to the study data.SummaryDifference0.1%

- Check84 days agoChange DetectedA new bibliographic citation by Reike MJ et al. was added to Publications, detailing a 2024 Clin Genitourin Cancer article related to the PURE-01 study. The page revision was updated to v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.